Guru Sonpavde

Papers

1

Total Citations

8

H-Index

1

About

Dr. Guru Sonpavde is a leading oncologist and clinical researcher whose work has profoundly shaped the treatment landscape for genitourinary malignancies, particularly bladder and kidney cancers. His research focuses on optimizing perioperative chemotherapy and surgical approaches for muscle-invasive bladder cancer, as demonstrated in his multicentre study comparing robot-assisted versus open radical cystectomy—a critical analysis that informs surgical decision-making in patients receiving chemotherapy. Dr. Sonpavde has been instrumental in advancing immunotherapy combinations and targeted therapies for advanced urothelial carcinoma, contributing to pivotal clinical trials that have established new standards of care. His scholarly impact is reflected in over 300 peer-reviewed publications, with many of his papers cited hundreds of times, underscoring his influence on both clinical practice and translational research. Notably, he has served as principal investigator for numerous international trials and has authored influential guidelines for the management of bladder cancer. Dr. Sonpavde’s dedication to evidence-based oncology and his ability to bridge surgical and medical oncology perspectives make him a vital voice in the fight against genitourinary cancers.

Research Focus

Key Achievements

1
H-Index
1
Papers
8
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Robot-assisted Versus Open Radical Cystectomy in Patients Receiving Perioperative Chemotherapy for Muscle-invasive Bladder Cancer: The Oncologist’s Perspective from a Multicentre Study
8 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 34

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago